PAX8 and neuroendocrine neoplasm: It was reported that among well-differentiated neuroendocrine tumors, only tumors from the pancreas were PAX8-positive (14/25, 56%) whereas no cases of pulmonary, ileal, duodenal, rectal or ovarian well-differentiated neuroendocrine tumors were positive for PAX8 (8).